Table 4.

Additional PRIO Data for COPD Patients in the APEX-COPD Registry (N = 1,354)

VariableAPEX-COPD Registry
Sample SizeNo. (%)
COPD assessment testn = 1,322 
  < 10 (Low) 238 (18.0)
  10-20 (Medium) 504 (38.1)
  21-30 (High) 453 (34.3)
  >30 (Very high) 127 (9.6)
mMRCn = 1,315 
  Grade 0 258 (19.6)
  Grade 1 469 (35.7)
  Grade 2 325 (24.7)
  Grade 3 195 (14.8)
  Grade 4 68 (5.2)
GOLD characteristicsn = 1,236 
  Less symptoms, low risk (GOLD A) 178 (14.4)
  More symptoms, low risk (GOLD B) 586 (47.4)
  Less symptoms, high risk (GOLD C) 37 (3.0)
  More symptoms, high risk (GOLD D) 435 (35.2)
Number of exacerbations in the past 12 monthsn = 1,294 
  0 648 (50.1)
  1 241 (18.6)
  2 139 (10.7)
  3+ 266 (20.6)
Number of hospitalizations in the past 12 monthsn = 1,246 
  0 1,000 (80.3)
  1 123 (9.9)
  2 45 (3.6)
  3+ 78 (6.2)
Smoking statusn = 1,327 
  Smokers 414 (31.2)
  Ex-smokers 751 (56.6)
  Non-smokers 162 (12.2)
  • APEX = Advancing the Patient Experience; CT = chronic obstructive pulmonary disease assessment test; COPD = chronic obstructive pulmonary disease; GOLD = Global Initiative for chronic Obstructive Lung Disease; mMRC = modified Medical Research Council; PRI = patient reported information; PRIO = patient reported information/outcomes.

  • Note: Missing data for each variable.